The goal of the Cancer Epidemiology Program is to study environmental, genetic, and molecular risks for cancer and cancer outcomes with an emphasis on disparities. Because we are a public comprehensive cancer center and because North Carolina in many ways mimics the American population, the Program addresses these important questions through multidimensional North Carolina population-based and hospital-based studies. Notable translational cross-program research and high impact publications have been obtained in an inter-disciplinary manner with members of the cancer control and prevention, clinical, genetics, breast, cancer, cell biology and other programs. Program members conduct research with great impact, including population- based studies in breast, colon, prostate, and head and neck cancer, throughout our catchment area (the state of North Carolina) and at UNC Hospital; and the program is focused on cancer health disparities, especially black-white differences. This innovative research model successfully integrates classic risk factor epidemiology, molecular and genetic epidemiology, tumor biology, clinical factors, and prospective follow-up for outcomes. For example, the Program?s Carolina Breast Cancer Study has reshaped our understanding of disparities in breast cancer risk factors, tumor biology, and mortality among African-American women. New and novel North Carolina-based studies in bladder, head and neck, and kidney cancer are planned. Program members collaborate in national and international consortia and with other cancer centers. The Program brings value to the Center through population- and hospital based studies that include systematic collection of exposure, outcome data, and biospecimens, a unique shared resource (Rapid Case Ascertainment), and its expertise in epidemiologic methods development and application. The Program effectively obtains value from the center through UNC Lineberger?s strong support for faculty recruitments, extensive support for important shared resources and developmental funds, which members leverage. The UNC Lineberger strategic plan emphasis on optimizing cancer outcomes in North Carolina led to significant investment across the population sciences including significant faculty recruiting. CE recruited 11 new program members both nationally- recognized senior investigators and promising junior faculty. There are 23 members from 7 different departments in the Schools of Public Health and Medicine and the College of Arts and Sciences. During the last funding period, program members have published 629 cancer- related articles (38% collaborative). In 2014, our program members held 53 grants and $13M (total cost) in annual extramural funding, including 25 grants and $6.6M (total costs) from the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-41
Application #
9316495
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2016-12-01
Budget End
2017-11-30
Support Year
41
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Suzuki, Aussie; Long, Sarah K; Salmon, Edward D (2018) An optimized method for 3D fluorescence co-localization applied to human kinetochore protein architecture. Elife 7:
Mohan, Vishwa; Sullivan, Chelsea S; Guo, Jiami et al. (2018) Temporal Regulation of Dendritic Spines Through NrCAM-Semaphorin3F Receptor Signaling in Developing Cortical Pyramidal Neurons. Cereb Cortex :
Haase, Karen P; Fox, Jaime C; Byrnes, Amy E et al. (2018) Stu2 uses a 15-nm parallel coiled coil for kinetochore localization and concomitant regulation of the mitotic spindle. Mol Biol Cell 29:285-294
Nicholls, Thomas J; Nadalutti, Cristina A; Motori, Elisa et al. (2018) Topoisomerase 3? Is Required for Decatenation and Segregation of Human mtDNA. Mol Cell 69:9-23.e6
Becker, Silke; Wang, Haibo; Simmons, Aaron B et al. (2018) Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms. Sci Rep 8:2003
Kim, R D; Alberts, S R; Peña, C et al. (2018) Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer. Br J Cancer 118:462-470
Chiang, Yun-Chen; Park, In-Young; Terzo, Esteban A et al. (2018) SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. Cancer Res 78:3135-3146
Reuland, Daniel S; Cubillos, Laura; Brenner, Alison T et al. (2018) A pre-post study testing a lung cancer screening decision aid in primary care. BMC Med Inform Decis Mak 18:5
Kornides, Melanie L; McRee, Annie-Laurie; Gilkey, Melissa B (2018) Parents Who Decline HPV Vaccination: Who Later Accepts and Why? Acad Pediatr 18:S37-S43
Ramsingh, Arlene I; Gray, Steven J; Reilly, Andrew et al. (2018) Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation. PLoS One 13:e0198154

Showing the most recent 10 out of 1525 publications